Cure HHT   Report issue

Foundation Phase 3
Founded: Monkton MD United States (1991)

Organization Overview

First Clinical Trial
2019
NCT03850964
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Cure HHT